12 High Growth Low Debt Stocks to Invest in Now

8. GeneDx Holdings Corp. (NASDAQ:WGS)

EPS Growth Rate (Next 5 Years): 119.03%

GeneDx Holdings Corp. (NASDAQ:WGS) is a genomics company specializing in personalized health insights to improve diagnosis, treatment, and drug discovery.

GeneDx Holdings Corp. (NASDAQ:WGS) is driving the push for newborn genetic testing, using whole genome sequencing to diagnose rare diseases like epilepsy and cystic fibrosis early for timely intervention. CEO Katherine Stueland highlighted strong parental interest, with over 70% enrollment in studies focused on clinically actionable conditions. While insurance coverage remains a challenge, GeneDx’s initiative positions it as a leader in genomic diagnostics, aiming to revolutionize pediatric healthcare.

GeneDx Holdings Corp. (NASDAQ:WGS) delivered strong FY2024 results, with revenue growing 56% YoY to $302.3 million, driven by an 88% increase in exome and genome test revenue to $233.5 million. The company achieved an adjusted net income of $6.7 million, while the GAAP net loss was $52.3 million. Operating expenses declined 14% YoY to $185.9 million, highlighting cost discipline. With $142.2 million in cash, GeneDx is well-positioned for continued growth, supported by strong demand for its genomic testing solutions. WGS is one of the best high growth stocks.